THRX

Theseus Pharmaceuticals, Inc. THRX

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode THRX VACC LENZ LSB SPPI FSTX TCRT ZVRA SELB CRGX
6M 38.74 % 103.25 % -42.36 % -51.02 % 31.75 % 16.15 % -30.35 % -5.30 % -37.06 % 17.63 %
YTD 1.63 % 108.33 % -39.32 % -82.63 % 167.97 % 15.40 % 73.60 % -1.08 % -23.37 % -70.30 %
1Y -47.95 % 117.39 % -45.51 % -78.38 % -10.87 % 100.00 % 74.49 % 0.87 % -32.73 % -81.53 %
3Y -78.12 % -64.54 % 27.72 % -99.37 % -75.65 % 667.24 % -95.46 % 110.32 % -72.80 % -69.24 %
5Y -78.12 % -64.54 % -80.40 % -99.34 % -95.47 % -49.50 % -99.21 % -24.78 % -84.04 % -69.24 %
10Y -78.12 % -64.54 % -80.40 % -99.34 % -86.62 % -35.86 % -99.73 % -97.20 % -93.71 % -69.24 %
From the beginning -78.12 % -64.54 % -80.40 % -99.34 % -99.25 % -35.86 % -99.86 % -95.16 % -93.71 % -69.24 %

Dividend

Theseus Pharmaceuticals, Inc.

LENZ Therapeutics, Inc.

Spectrum Pharmaceuticals, Inc.